Posted inBusiness FDA accepts Verastem NDA for priority review, stock jumps 20% (update) Posted by admin December 30, 2024No Comments [ad_1] FDA accepts Verastem NDA for priority review, stock jumps 20% (update) [ad_2] admin View All Posts Post navigation Previous Post Digital Ally files to sell 808,377 shares of common stock for holdersNext PostCommunity National Bank promotes Christopher L. Caldwell to CEO